Asymptomatic Low Ankle-Brachial Index in Vascular Surgery Patients: A Predictor of Perioperative Myocardial Damage  by Flu, W.-J. et al.
Selected Abstracts from the January Issue of the
European Journal of Vascular and Endovascular SurgeryPiergiorgio Cao, MD, FRCS, Editor-in-Chief, and Jean-Baptiste Ricco, MD, PhD, Senior EditorUse of Non-randomised Evidence Alongside Randomised Trials in a
Systematic Review of Endovascular Aneurysm Repair: Strengths and
Limitations
Chambers Duncan, Fayter Debra, Paton Fiona, Woolacott Nerys Eur J Vasc
Endovasc Surg 2010;39:26-34.
Objective: To assess whether limitations of randomised controlled
trials (RCTs) of endovascular aneurysm repair (EVAR) can be addressed by
evidence from non-randomised studies.
Design: Analysis of data from a systematic review.
Methods: We conducted a review of EVAR versus open repair or
non-surgical management of abdominal aortic aneurysms. In addition to
RCTs, we included pre-specified registries of EVAR and open repair.
Results: The six included RCTs randomised patients in 2003 and
earlier. Of the three registries included, one contributed data on a large
(8000) sample of patients treated with newer generation EVAR devices
and followed up for up to 8 years. However, treatment dates of these patients
overlapped with those of the RCTs. The other registries were of limited
usefulness. A large (45,000) controlled observational study published
while the review was in progress broadly supported the findings of RCTs
comparing EVAR with open surgery. A comparison of outcomes across all
studies did not support the hypothesis that the findings of the RCTs are no
longer representative of clinical practice.
Conclusions: Both randomised and non-randomised sources of evi-
dence have strengths and weaknesses for assessing the effectiveness of
EVAR. Further research should explore the optimum use of registry data,
including patient-level analyses.
Intra-aneurysm Sac Pressure in Patients with Unchanged AAA Diam-
eter after EVAR
Dias N.V., Ivancev K., Kölbel T., Resch T., Malina M., Sonesson B. Eur J
Vasc Endovasc Surg 2010;39:35-41.
Objective: To study intra-aneurysm sac pressure and subsequent ab-
dominal aortic aneurysm (AAA) diameter changes in patients without en-
doleaks that remain unchanged in AAA diameter more than 1 year after
endovascular aneurysm repair (EVAR).
Methods: A total of 23 patients underwent direct intra-aneurysm sac
pressure (DISP) measurements 16 months (IQR: 14–35 months) after
EVAR. Tip-pressure sensors were used through translumbar AAA puncture.
Mean pressure index (MPI) was calculated as the percentage of mean
intra-aneurysm pressure relative to the simultaneous mean intra-aortic pres-
sure. Aneurysm expansion or shrinkage was assumed whenever the diameter
change was  5 mm. Values are presented as median and interquartile
range.
Results: In 18 patients, no fluid was obtained upon AAA puncture
(group A). In five patients, fluid was obtained (group B). In group A,
follow-up continued for 29 months (IQR: 15–35 months) after DISP; five
AAAs shrank, 10 remained unchanged and three expanded (MPIs of 26%
(IQR: 18–42%), 28% (IQR: 20–48%) and 63% (IQR: 47–83%) and intra-
sac pulse pressures of 3 mmHg (IQR: 0–5 mmHg), 4 mmHg (IQR:
2–8 mm Hg) and 12 mmHg (IQR: 6–20 mmHg), respectively, for the
three subgroups). MPI and intra-sac pulse pressures were higher in AAAs
that subsequently expanded (P  0.073 and 0.017, respectively). MPI and
pulse pressure correlated with total diameter change (r  0.49, P  0.039
and r  0.39, P  0.109, respectively). Pulse pressure had a greater influ-
ence thanMPI on diameter change (R2  0.346, P  0.041, beta standard-
ised coefficient of 0.121 for MPI and 0.502 for pulse pressure). Similar
results with stronger, and significant correlation to pulse pressure were
obtained when relative diameter changes were used (r  0.55, P  0.017).
In group B, MPI and AAA pulse pressure were 32% (IQR: 18–37%) and
1 mmHg (IQR: 0–6 mmHg), respectively. After 36 months (IQR: 21–38
months), one AAA shrank, three continued unchanged while one expanded.
Conclusions: AAAs without endoleak and unchanged diameter more
than 1 year after EVAR will often continue unchanged. Expansion can
eventually occur in the absence of intra-sac fluid accumulation and is
associated with higher and more pulsatile intra-sac pressure. However, in
patients with intra-sac fluid, expansion can occur with low intra-sac pres-
sures.Re-interventions, Readmissions and Discharge Destination: Modern
Metrics for the Assessment of the Quality of Care
Holt P.J.E., Poloniecki J.D., Hofman D., Hinchliffe R.J., Loftus I.M.,
Thompson M.M. Eur J Vasc Endovasc Surg 2010;39:49-54.
Aim: To determine whether administrative data can be used to deter-
mine metrics to inform the quality agenda. To determine the relationship
between these metrics and the method of abdominal aortic aneurysm (AAA)
repair undertaken.
Methods: The Hospital Episode Statistics (HES) data were taken for a
5-year period (01.04.2003–31.03.2008). Cases of elective AAA repair were
identified. Outcomes were determined in terms of mortality, discharge
destination, re-intervention rates and emergency readmission rates. The
results were interpreted in light of whether AAA repair was open or endo-
vascular and whether patients were octogenarians or younger patients.
Results: There were 18,060 elective AAA repairs with a mean in-
hospital mortality rate of 5.9%. Of these 14,141 were open repairs with a
mean mortality of 6.5% and 3919 EVAR (22%) with a mean mortality of
3.8%. EVAR patients were less likely to be discharged to ongoing care (p 
0.001) but were associated with a higher rate of re-intervention (p  0.001)
than open repairs. No differences were seen in one-year readmission rates.
Octogenarians were more likely to undergo EVAR (p  0.001), to be
readmitted within 30-days (p  0.009), to require further interventions on
their index admission (p 0.001) and less likely to be discharged home (p
0.001) than younger patients.
Conclusion: Administrative data can be used to identify metrics other
than mortality and length of stay. These metrics might be used to inform
service provision. In particular for AAA repair, differences in these outcomes
were identified between open repair and EVAR and between octogenarians
and younger patients.
Patient Preference for SurgicalMethod of Abdominal Aortic Aneurysm
Repair: Postal Survey
Reise J.A., Sheldon H., Earnshaw J., Naylor A.R., Dick F., Powell J.T.,
Greenhalgh R.M. Eur J Vasc Endovasc Surg 2010;39:55-61.
Objectives: To determine whether men with small abdominal aortic
aneurysm have a preference between either endovascular or open aneurysm
repair for future treatment.
Design: Prospective study of self-declared treatment preference follow-
ing receipt of a validated patient information pack.
Participants: Men aged 65–84 years (n  237) with asymptomatic
aneurysm (4.0–5.4 cm) detected by population-based screening.
Methods: An unbiased, validated patient information pack and ques-
tionnaire were developed to conduct a postal survey.
Results: One hundred sixty seven participants (70%) returned a com-
pleted questionnaire; 24 (10%) did not respond at all. Initially, only 38
(23%) declared a treatment preference. After reading the information pack,
130 participants (80%) declared a treatment preference: 30 preferred open
repair (18%), 77 endovascular repair (46%), 23 were happy with either
option (14%) and only 34 remained without any preference (20%). Nearly all
(92%) thought that the information pack had prepared them well for future
discussions with clinicians and with no single feature identified as influencing
the preference-making process, 66 respondents (40%) still opted to “take the
advice of the doctor”.
Conclusion: The patient information pack facilitated the development
of treatment preferences with endovascular repair being preferred to open
repair. Nevertheless for patient-centred care, vascular centres must continue
to safely provide both open and endovascular repair.
Asymptomatic Low Ankle-Brachial Index in Vascular Surgery Patients:
A Predictor of Perioperative Myocardial Damage
Flu W.-J., van Kuijk J.-P., Voûte M.T., Kuiper R., Verhagen H.J.M., Bax
J.J., Poldermans D. Eur J Vasc Endovasc Surg 2010;39:62-9.
Objectives: This study evaluated the prognostic value of asymptomatic
low ankle-brachial index (ABI) to predict perioperative myocardial damage,
incremental to conventional cardiac risk factors imbedded in cardiac risk
indices (Revised Cardiac index and Adapted Lee index).
Materials and methods: Preoperative ABI measurements were per-
formed in 627 consecutive vascular surgery patients (carotid artery or
abdominal aortic aneurysm repair). An ABI  0.90 was considered abnor-
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were excluded. Serial troponin-T measurements were performed routinely
before and after surgery. The main study endpoint was perioperative myo-
cardial damage, the composite of myocardial ischaemia and infarction.
Multivariate regression analyses, adjusted for conventional risk factors, eval-
uated the relation between asymptomatic low ABI and perioperative myo-
cardial damage.
Results: In total, 148 (23%) patients had asymptomatic low ABI (mean
0.73, standard deviation  0.13). Perioperative myocardial damage was
recorded in 107 (18%) patients. Multivariate regression analyses demon-
strated that asymptomatic low ABI was associated with an increased risk of
perioperative myocardial damage (odds ratio (OR): 2.4, 95% CI: 1.4–4.2)
Conclusions:This study demonstrated that asymptomatic low ABI has
a prognostic value to predict perioperative myocardial damage in vascular
surgery patients, incremental to risk factors imbedded in conventional
cardiac risk indices.
A Systematic Review of Implementation of Established Recommended
Secondary Prevention Measures in Patients with PAOD
Flu H.C., Tamsma J.T., Lindeman J.H.N., Hamming J.F., Lardenoye
J.H.P. Eur J Vasc Endovasc Surg 2010;39:70-86.
Objective: Since patients with peripheral arterial occlusive disease
(PAOD) are at high-risk for cardiovascular morbidity and mortality, preven-
tive measures aimed to reduce cardiovascular adverse events are advocated in
the current guidelines. We conducted a systematic review to assess the
implementation of secondary prevention (SP) measures in PAOD patients.
Methods: PubMed, Cochrane Library, EMBASE and Web of Science
databases were searched to perform a systematic review of the literature from
1999 till June 2008 on SP for PAOD patients. Assessment of study quality
was done following the Cochrane Library review system. The record out-
comes were antiplatelet agents, heart rate lowering agents, blood pressure
lowering agents, lipid lowering agents, glucose lowering agents, smoking
cessation and walking exercise.
Results: From a total of 2137 identified studies, 83 observational
studies met the inclusion criteria, of which 24 were included in the system-
atic review comprising 34 157 patients. These patients suffered from coro-
nary artery disease (n  3516, 41%), myocardial infraction (n  2647,
38%), angina pectoris (n  1790, 31%), congestive heart failure (n  2052,
14%), diabetes mellitus (n  10 690, 31%),hypertension (n  20 823, 73%)
and hyperlipidaemia (n  15 067, 64%). Contrary to what the guidelines
prescribe, antiplatelet agents, heart rate lowering agents, blood pressure
lowering agents and lipid lowering agents were prescribed in 63%, 34%, 46%
and 45% of the patients, respectively. Glucose lowering agents were pre-
scribed in 81% and smoking cessation in 39% of the patients.
Conclusion: The majority of patients suffering from PAOD do not
receive the entire approach of SP measures as suggested by the current
guidelines. To our knowledge, the cause of this undertreatment is multifac-
torial: patient, physician or health-care-related.
Endovenous Laser Ablation (980 nm) of the Small Saphenous Vein in
a Series of 147 Limbs with a 3-Year Follow-upReaders can access EJVES articles at http://intl.eAim: This study aims to demonstrate the treatment outcomes of
endovenous laser ablation (EVLA) of incompetent small saphenous veins
(SSVs) with a 980-nm diode laser.
Materials andmethods: Between 1 June 2003 and 30 June 2006, 128
patients (147 limbs) with varicose veins and reflux in the SSV on duplex
ultrasound (US) examination were treated with a 980-nm diode laser under
US guidance. EVLA was performed using pulsed mode with a power of
10 W. The pulse duration (1.5–3 s) was chosen to deliver a linear en-
dovenous energy density (LEED) depending on the SSV diameter measured
1.5 cm below the sapheno-popliteal junction (SPJ) with the patient stand-
ing. For SSV diameters between 2 and 4.5 mm, the LEED applied was
50 J cm1. The LEED was 70 J cm1 for 4.5–7 mm, 90 J cm1 for
7–10 mm. Patients were evaluated at 1-week, 1-month, 1-year, 2-year and
3-year follow-up.
Results: The initial technical success rate was 100% in 147 patients.
The SSV remained closed in 114 of 117 limbs (97%) after 1 year, all of 61
limbs after 2 years and all of 30 limbs after 3 years. For the three SSVs where
re-canalisation was observed, the diameter was greater than 9 mm. Major
complications have not been detected and, in particular, there was no deep
venous thrombosis (DVT). Ecchymoses were seen in 60% with a median
duration of 2 weeks. Temporary paraesthesia (mostly hypoaesthesia) was
observed in 40% of treated legs with a median duration of 2 weeks. The
maximum duration did not exceed 4 weeks. No skin discolouration, super-
ficial burn, thrombophlebitis or palpable induration was observed.
Conclusion: EVLA of the incompetent SSV with a 980-nm diode laser
appears to be an extremely safe technique. After successful treatment, there
is a very low rate of re-canalisation of the SSV. Obliteration of the SSV was
confirmed at 1-, 2- and 3-year follow-up; this study suggests that this
procedure will provide a lasting result.
Radiofrequency Ablation vs Conventional Surgery for Varicose Veins –
a Comparison of Treatment Costs in a Randomised Trial
Subramonia S., Lees T. Eur J Vasc Endovasc Surg 2010;39:104-11.
Objective: To compare the costs involved (from procedure to recov-
ery) following radiofrequency ablation and conventional surgery for lower
limb varicose veins in a selected population.
Design: Prospective randomised controlled trial.
Methods Patients with symptomatic great saphenous varicose veins
suitable for radiofrequency ablation were randomised to either RF ablation
or surgery (sapheno-femoral ligation and stripping). The hospital, general
practice and patient costs incurred until full recovery and the indirect cost to
society, due to sickness leave after surgery, were calculated to indicate mean
cost per patient under each category.
Results: Ninety three patients were randomised. Eighty eight patients
(47 – RF ablation, 41 – surgery) underwent the allocated intervention.
Ablation took longer to perform than surgery (mean 76.8 vs 47.0 min,
p  .001). Ablation was more expensive (mean hospital cost per patient
£1275.90 vs £559.13) but enabled patients to return to work 1 week earlier
than after surgery (mean 12.2 vs 19.8 days, p  0.006). Based on the
Annual Survey of Hours and Earnings (Office of National Statistics, UK) for
full time employees, the cost per working hour gained after ablation was
£6.94 (95% CI 6.26, 7.62).
Conclusion: The increased cost of radiofrequency ablation is partly
Desmyttère J., Grard C., Stalnikiewicz G., Wassmer B., Mordon S. Eur J
Vasc Endovasc Surg 2010;39:99-103.
offset by a quicker return to work in the employed group
(ISRCTN29015169http://www.controlled-trials.com).lsevierhealth.com/journals/ejvs/default.cfm
